Tong Ren Tang Technologies Renews Procurement, Sale Deals With Controlling Shareholder

MT Newswires Live

2025/09/30

Beijing Tong Ren Tang's (SHA:600085) subsidiary, Tong Ren Tang Technologies (HKG:1666), renewed two agreements with the company's controlling shareholder, China Beijing Tong Ren Tang (Group), for two more years, according to a Shanghai bourse filing on Tuesday.

The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.

The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2571108394"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2571108394\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2571108394?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-30 12:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571108394","market":"sh","top_or_hot":-1,"title":"Tong Ren Tang Technologies Renews Procurement, Sale Deals With Controlling Shareholder","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/600085\">Beijing Tong Ren Tang</a>'s (SHA:600085) subsidiary, <a href=\"https://laohu8.com/S/TGRNF\">Tong Ren Tang Technologies</a> (HKG:1666), renewed two agreements with the company's controlling shareholder, China Beijing <a href=\"https://laohu8.com/S/01666\">Tong Ren Tang</a> (Group), for two more years, according to a Shanghai bourse filing on Tuesday.</p><p>The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.</p><p>The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tong Ren Tang Technologies Renews Procurement, Sale Deals With Controlling Shareholder</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTong Ren Tang Technologies Renews Procurement, Sale Deals With Controlling Shareholder\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-09-30 12:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/600085\">Beijing Tong Ren Tang</a>'s (SHA:600085) subsidiary, <a href=\"https://laohu8.com/S/TGRNF\">Tong Ren Tang Technologies</a> (HKG:1666), renewed two agreements with the company's controlling shareholder, China Beijing <a href=\"https://laohu8.com/S/01666\">Tong Ren Tang</a> (Group), for two more years, according to a Shanghai bourse filing on Tuesday.</p><p>The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.</p><p>The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0183","symbol_name":"MSCI概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2571108394","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571108394","pubTimestamp":1759205114,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Beijing Tong Ren Tang's  subsidiary, Tong Ren Tang Technologies , renewed two agreements with the company's controlling shareholder, China Beijing Tong Ren Tang , for two more years, according to a Shanghai bourse filing on Tuesday.The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600085":"同仁堂","BK0183":"MSCI概念","BK0012":"证金概念","BK0028":"国家队","BK1515":"抗疫概念","BK0086":"举牌","LU1688375341.USD":"贝莱德中国灵活股票基金","BK1583":"高瓴概念","BK0188":"融资融券","BK1191":"制药","BK0097":"医药电商","BK0196":"行业龙头","01666":"同仁堂科技","TGRNF":"Tong Ren Tang Technologies","BK0239":"医药制造","BK1606":"中医药概念","BK0113":"养老产业","BK4007":"制药"},"translate_title":"同仁堂科技与控股股东续签采购、销售协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600085":0.9,"01666":1,"TGRNF":1.5},"content_text":"Beijing Tong Ren Tang's (SHA:600085) subsidiary, Tong Ren Tang Technologies (HKG:1666), renewed two agreements with the company's controlling shareholder, China Beijing Tong Ren Tang (Group), for two more years, according to a Shanghai bourse filing on Tuesday.The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}